Monocyte/macrophage functions in patients with squamous cell carcinoma of the oral cavity.

Peripheral blood monocytes and draining lymph node macrophages from patients with squamous cell carcinoma of the oral cavity, monocytes from patients with oral leukoplakia and those from healthy donors were assessed for FcR. HLA-DR expression and interleukin-1 (IL-1) production after activation with LPS or IFN gamma. Monocyte cytotoxicity was also tested after activation with LPS, IFN gamma, IL-2 singly, or in combinations at suboptimal concentrations. The results showed that the percentage of activated monocytes expressing FcR was significantly low in untreated oral cancer patients, however, the proportion of HLA-DR positive cells was normal. The unstimulated monocytes from oral cancer patients showed spontaneous generation of IL-1. Upon activation, few patients could produce IL-1 to normal levels. The unstimulated monocytes from untreated patients and treated patients with recurrence also exhibit significantly higher tumoricidal activity. Treatment of monocytes with combinations of two modulators (IFN gamma, LPS and IL-2) induced significantly higher cytotoxicity.

[1]  N. Krishnan,et al.  Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients. , 1989, Journal of clinical & laboratory immunology.

[2]  E. Myers,et al.  Cancer of the Head and Neck , 1989 .

[3]  S. Gangal,et al.  Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  N. Krishnan,et al.  Lymphokine‐activated killer‐cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer , 1989, International journal of cancer.

[5]  D. Morton,et al.  Interleukin‐1 and tumor necrosis factor production by tumor‐associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients , 1988, International journal of cancer.

[6]  O. Garraud,et al.  Impairment of monocyte functions in advanced head and neck cancer. , 1988, Immunology letters.

[7]  G. Wolf,et al.  Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma. , 1988, Head & neck surgery.

[8]  C. Balch,et al.  Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells. , 1987, Cellular immunology.

[9]  N. Hogg,et al.  Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. , 1987, Journal of the National Cancer Institute.

[10]  M. Kamber,et al.  Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. , 1987, Lymphokine research.

[11]  R. Cantrell,et al.  Interleukin-2 production in head and neck cancer patients. , 1985, American journal of surgery.

[12]  D. Saranath,et al.  Cell‐mediated immune status in patients with squamous cell carcinoma of the oral cavity , 1985, Cancer.

[13]  B. Stromberg,et al.  The ability of macrophages from head and neck cancer patients to kill tumor cells: Effect of prostaglandin inhibitors on cytotoxicity , 1984, Cancer.

[14]  J. Vilček,et al.  Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma. , 1984, Cellular immunology.

[15]  C. Parish,et al.  An improved colorimetric assay for T cell cytotoxicity in vitro. , 1984, Journal of immunological methods.

[16]  W. Panje,et al.  Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre‐ and postirradiation therapy , 1982, Cancer.

[17]  J. Terz,et al.  Cytotoxicity to tumor cells of monocytes from normal individuals and cancer patients , 1980, International journal of cancer.

[18]  J. Rhodes.  Altered expression of human monocyte Fc receptors in malignant disease , 1977, Nature.

[19]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.